SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Remedent, Inc. – ‘RW’ on 1/29/04

On:  Thursday, 1/29/04, at 4:25pm ET   ·   Accession #:  1144204-4-703   ·   File #:  333-96999

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 1/29/04  Remedent, Inc.                    RW                     1:4K                                     Vintage/FA

Registration Withdrawal Request
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: RW          Registration Withdrawal Request                        2      8K 

RW1st Page of 2TOCTopPreviousNextBottomJust 1st
 

REMEDENT USA, INC. XAVIER DE COCKLAAN 42 9831 DEURLE, BELGIUM January 29, 2004 VIA EDGAR AND OVERNIGHT DELIVERY Securities and Exchange Commission Division of Corporation Finance 450 Fifth Street N.W. Washington, D.C. 20549 Re: Remedent USA, Inc. Request to Withdraw Registration Statement on Form SB-2 (File No. 333-96999) Ladies and Gentlemen: Pursuant to Rule 477 promulgated under the Securities Act of 1933, as amended (the "Securities Act"), Remedent USA, Inc., a Nevada corporation (the "Company"), hereby applies for an order granting the immediate withdrawal of its Registration Statement on Form SB-2 (File No. 333-96999) together with exhibits thereto (the "Registration Statement"), on grounds that withdrawal of the Registration Statement is consistent with the public interest and the protection of investors as contemplated by Rule 477(a). The Registration Statement was originally filed with the Securities and Exchange Commission (the "Commission") on August 24, 2002. The Registration Statement was filed in connection with the proposed public offering of shares of the Company's common stock (the "Shares"). Because of the high expenses of proceeding with the public offering contemplated by the Registration Statement, the Company has determined not to pursue the offering at this time. Therefore the Company's board of directors and management believe that withdrawal of the Registration Statement is appropriate. The Company confirms that no preliminary prospectuses have been distributed, no securities have been issued or sold pursuant to the Registration Statement or the prospectus contained therein and all activity regarding the proposed public offering has been discontinued. The Company requests that, pursuant to Rule 477(c), an order with the date of granting of the request for withdrawal be included in the file for the Registration Statement on Form SB-2 in the following manner: "Withdrawn upon request of the Registrant, the Commission consenting thereto." Pursuant to Rule 477(c), the Company hereby advises the Commission that the Company may undertake a subsequent private offering in reliance on Rule 155(c) under the Securities Act.
RWLast Page of 2TOC1stPreviousNextBottomJust 2nd
The Company also requests that all fees paid to the Commission in connection with the filing of the Registration Statement be credited to the Company's account with the Commission for future use. Sincerely, REMEDENT, USA, INC. /s/ Robin List ---------------------------- By: Robin List Its: Chief Executive Officer cc: Ms. Peggy Fisher -- Securities and Exchange Commission

Dates Referenced Herein

Referenced-On Page
This ‘RW’ Filing    Date First  Last      Other Filings
Filed on:1/29/041None on these Dates
8/24/021
 List all Filings 
Top
Filing Submission 0001144204-04-000703   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Tue., Apr. 30, 12:50:57.1am ET